<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GBS Clinical Quick-Scan</title>
    <style>
        :root {
            /* Palette */
            --bg-color: #f4f6f9;
            --text-main: #2c3e50;
            --text-light: #637282;
            
            /* Semantic Colors */
            --danger-bg: #ffebee;
            --danger-border: #ef5350;
            --danger-text: #c62828;
            
            --success-bg: #e8f5e9;
            --success-border: #66bb6a;
            --success-text: #2e7d32;
            
            --info-bg: #e3f2fd;
            --info-border: #42a5f5;
            --info-text: #1565c0;
            
            --white: #ffffff;
            --shadow: 0 4px 6px rgba(0,0,0,0.05), 0 1px 3px rgba(0,0,0,0.1);
            --shadow-hover: 0 10px 15px rgba(0,0,0,0.1), 0 4px 6px rgba(0,0,0,0.05);
            --radius: 12px;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif; }

        body {
            background-color: var(--bg-color);
            color: var(--text-main);
            padding: 20px;
            max-width: 1200px;
            margin: 0 auto;
        }

        /* --- Header --- */
        header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 20px;
            background: var(--white);
            padding: 20px;
            border-radius: var(--radius);
            box-shadow: var(--shadow);
            border-left: 8px solid var(--info-border);
        }

        .header-title h1 { font-size: 1.5rem; color: var(--text-main); }
        .header-title p { font-size: 0.9rem; color: var(--text-light); margin-top: 4px; }
        .meta-badge { background: var(--info-bg); color: var(--info-text); padding: 5px 10px; border-radius: 20px; font-size: 0.8rem; font-weight: 600; }

        /* --- Critical Alert Banner --- */
        .alert-banner {
            background: var(--danger-text);
            color: white;
            padding: 15px 20px;
            border-radius: var(--radius);
            margin-bottom: 25px;
            display: flex;
            align-items: center;
            gap: 15px;
            box-shadow: var(--shadow);
            animation: pulse 2s infinite;
        }

        @keyframes pulse {
            0% { box-shadow: 0 0 0 0 rgba(198, 40, 40, 0.4); }
            70% { box-shadow: 0 0 0 10px rgba(198, 40, 40, 0); }
            100% { box-shadow: 0 0 0 0 rgba(198, 40, 40, 0); }
        }

        /* --- Navigation Tabs --- */
        .tabs { display: flex; gap: 10px; margin-bottom: 20px; overflow-x: auto; padding-bottom: 5px; }
        .tab-btn {
            padding: 10px 20px;
            border: none;
            background: var(--white);
            color: var(--text-light);
            border-radius: 30px;
            cursor: pointer;
            font-weight: 600;
            transition: all 0.3s ease;
            box-shadow: var(--shadow);
            white-space: nowrap;
        }
        .tab-btn:hover { transform: translateY(-2px); color: var(--info-text); }
        .tab-btn.active { background: var(--info-text); color: var(--white); }

        /* --- Main Content Area --- */
        .tab-content { display: none; animation: fadeIn 0.4s ease; }
        .tab-content.active { display: grid; }
        
        @keyframes fadeIn { from { opacity: 0; transform: translateY(10px); } to { opacity: 1; transform: translateY(0); } }

        /* --- Grid Layouts --- */
        .grid-2 { display: grid; grid-template-columns: repeat(auto-fit, minmax(350px, 1fr)); gap: 20px; }
        .grid-3 { display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 20px; }

        /* --- Cards --- */
        .card {
            background: var(--white);
            border-radius: var(--radius);
            padding: 20px;
            box-shadow: var(--shadow);
            transition: transform 0.2s, box-shadow 0.2s;
            border-top: 4px solid transparent;
            height: 100%;
            display: flex;
            flex-direction: column;
        }
        
        .card:hover { transform: translateY(-3px); box-shadow: var(--shadow-hover); }

        /* Card Variants */
        .card.danger { border-color: var(--danger-border); }
        .card.danger h3 { color: var(--danger-text); display: flex; align-items: center; gap: 8px; }
        
        .card.success { border-color: var(--success-border); }
        .card.success h3 { color: var(--success-text); display: flex; align-items: center; gap: 8px; }
        
        .card.info { border-color: var(--info-border); }
        .card.info h3 { color: var(--info-text); display: flex; align-items: center; gap: 8px; }

        .card h3 { font-size: 1.1rem; margin-bottom: 12px; display: flex; align-items: center; gap: 8px; }
        .card-content { flex: 1; }
        .card-content ul { list-style: none; padding-left: 5px; }
        .card-content li { position: relative; padding-left: 20px; margin-bottom: 8px; font-size: 0.95rem; line-height: 1.4; color: var(--text-main); }
        .card-content li::before {
            content: "‚Ä¢"; position: absolute; left: 0; color: var(--text-light); font-weight: bold;
        }

        /* --- Special Elements --- */
        .highlight-box {
            background: #f0f4f8;
            border-radius: 8px;
            padding: 10px;
            margin: 10px 0;
            border-left: 3px solid #b0bec5;
            font-size: 0.9rem;
        }

        .stat-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 10px; margin-top: 10px; }
        .stat-item { background: #fafafa; padding: 10px; border-radius: 8px; text-align: center; }
        .stat-val { display: block; font-weight: bold; font-size: 1.1rem; color: var(--text-main); }
        .stat-label { font-size: 0.75rem; color: var(--text-light); text-transform: uppercase; letter-spacing: 0.5px; }

        /* --- Tables --- */
        .comparison-table { width: 100%; border-collapse: collapse; font-size: 0.9rem; }
        .comparison-table th { text-align: left; padding: 10px; background: #f8f9fa; color: var(--text-light); border-bottom: 2px solid #e9ecef; }
        .comparison-table td { padding: 10px; border-bottom: 1px solid #e9ecef; }
        .comparison-table tr:last-child td { border-bottom: none; }
        
        /* --- Badges --- */
        .badge { display: inline-block; padding: 3px 8px; border-radius: 4px; font-size: 0.75rem; font-weight: bold; margin-right: 5px; }
        .badge-red { background: var(--danger-bg); color: var(--danger-text); }
        .badge-green { background: var(--success-bg); color: var(--success-text); }
        .badge-blue { background: var(--info-bg); color: var(--info-text); }

        /* SVG Icons */
        .icon { width: 20px; height: 20px; fill: currentColor; }

        /* Mobile Adjustments */
        @media (max-width: 600px) {
            .grid-2, .grid-3 { grid-template-columns: 1fr; }
            .header-title h1 { font-size: 1.2rem; }
        }
    </style>
</head>
<body>

    <!-- Header -->
    <header>
        <div class="header-title">
            <h1>Guillain-Barr√© Syndrome (GBS)</h1>
            <p>Acute Inflammatory Polyneuropathy - Quick Reference</p>
        </div>
        <div class="meta-badge">Last Updated: Nov 2022</div>
    </header>

    <!-- Critical Alert -->
    <div class="alert-banner">
        <svg class="icon" viewBox="0 0 24 24" style="width: 32px; height: 32px;">
            <path d="M12 2L1 21h22L12 2zm1 17h-2v-2h2v2zm0-4h-2v-4h2v4z"/>
        </svg>
        <div>
            <strong>AIRWAY & VENTILATION ALERT:</strong> 20-30% of patients develop respiratory failure. Monitor spirometry every 6 hours initially.
        </div>
    </div>

    <!-- Navigation Tabs -->
    <nav class="tabs">
        <button class="tab-btn active" onclick="switchTab('redflags')">üö© Red Flags & ICU</button>
        <button class="tab-btn" onclick="switchTab('diagnosis')">üîç Diagnosis</button>
        <button class="tab-btn" onclick="switchTab('management')">üíâ Management</button>
        <button class="tab-btn" onclick="switchTab('differentials')">‚öñÔ∏è Differentials</button>
    </nav>

    <!-- MAIN CONTENT SECTIONS -->

    <!-- SECTION 1: RED FLAGS -->
    <section id="redflags" class="tab-content active grid-2">
        
        <!-- ICU Admission Card -->
        <div class="card danger">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z"/></svg>
                ICU Admission Indications
            </h3>
            <div class="card-content">
                <ul>
                    <li><strong>Vital Capacity (VC):</strong> <span class="badge badge-red">&lt;20 mL/kg</span></li>
                    <li><strong>Max Inspiratory Pressure (MIP):</strong> Worse than -30 cm H‚ÇÇO</li>
                    <li><strong>Max Expiratory Pressure (MEP):</strong> &lt;40 cm H‚ÇÇO</li>
                    <li><strong>Rapid Progression:</strong> Quick deterioration of muscle strength</li>
                </ul>
            </div>
        </div>

        <!-- High Risk Clinical Signs -->
        <div class="card danger">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M12 21.35l-1.45-1.32C5.4 15.36 2 12.28 2 8.5 2 5.42 4.42 3 7.5 3c1.74 0 3.41.81 4.5 2.09C13.09 3.81 14.76 3 16.5 3 19.58 3 22 5.42 22 8.5c0 3.78-3.4 6.86-8.55 11.54L12 21.35z"/></svg>
                High Risk Clinical Signs
            </h3>
            <div class="card-content">
                <ul>
                    <li><strong>Bulbar Dysfunction:</strong> Facial weakness, dysphagia, slurred speech. (OR 17.5 for ventilation)</li>
                    <li><strong>Bilateral Facial Weakness:</strong> Significant predictor of respiratory failure</li>
                    <li><strong>Dysautonomia:</strong> Labile BP, sinus tachycardia, arrhythmias.</li>
                    <li><strong>Inability to lift head:</strong> OR 5.0 for mechanical ventilation.</li>
                </ul>
            </div>
        </div>

        <!-- Autonomic Instability -->
        <div class="card info" style="grid-column: span 2;">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M3 18h18v-2H3v2zm0-5h18v-2H3v2zm0-7v2h18V6H3z"/></svg>
                Monitoring Autonomic Dysfunction (Common)
            </h3>
            <div class="card-content" style="display: flex; flex-wrap: wrap; gap: 20px;">
                <div style="flex: 1; min-width: 250px;">
                    <p>Occurs in approx. 2/3 of patients. Can be life-threatening.</p>
                    <ul style="margin-top: 10px;">
                        <li><strong>Cardiac:</strong> Sinus tachycardia, bradycardia, asystole (esp. during suctioning).</li>
                        <li><strong>Hemodynamic:</strong> Hypertension, postural hypotension.</li>
                    </ul>
                </div>
                <div style="flex: 1; min-width: 250px; background: var(--info-bg); padding: 15px; border-radius: 8px;">
                    <strong>Action:</strong>
                    <ul>
                        <li>Continuous cardiac monitoring.</li>
                        <li>Alert for vagal stimulation during intubation/suctioning.</li>
                        <li>Treat hypertension only if severe (>180/120) or symptomatic.</li>
                    </ul>
                </div>
            </div>
        </div>
    </section>

    <!-- SECTION 2: DIAGNOSIS -->
    <section id="diagnosis" class="tab-content grid-2">
        
        <!-- Clinical Pattern -->
        <div class="card info">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M9 11.75c-.69 0-1.25.56-1.25 1.25s.56 1.25 1.25 1.25 1.25-.56 1.25-1.25-.56-1.25-1.25-1.25zm6 0c-.69 0-1.25.56-1.25 1.25s.56 1.25 1.25 1.25 1.25-.56 1.25-1.25-.56-1.25-1.25-1.25zM12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8 0-.29.02-.58.05-.86 2.36-1.05 4.23-2.98 5.21-5.37C11.07 8.33 14.05 10 17.42 10c.78 0 1.53-.09 2.25-.26.21.71.33 1.47.33 2.26 0 4.41-3.59 8-8 8z"/></svg>
                Classic Presentation
            </h3>
            <div class="card-content">
                <ul>
                    <li><strong>Progressive weakness:</strong> Ascending (Lower > Upper, Proximal > Distal).</li>
                    <li><strong>Timing:</strong> Reaches nadir in 2 weeks (80%) or 4 weeks (97%).</li>
                    <li><strong>Areflexia:</strong> Flaccid paralysis with absent reflexes.</li>
                    <li><strong>Pain:</strong> Back/leg pain (often misdiagnosed as disc herniation).</li>
                    <li><strong>Sensory:</strong> Paresthesia (tingling) common, objective sensory loss often mild.</li>
                </ul>
            </div>
        </div>

        <!-- Key Investigations -->
        <div class="card info">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zm-7 3c1.66 0 3 1.34 3 3s-1.34 3-3 3-3-1.34-3-3 1.34-3 3-3zm6 12H6v-1c0-2 4-3.1 6-3.1s6 1.1 6 3.1v1z"/></svg>
                Investigations
            </h3>
            <div class="card-content">
                <ul>
                    <li><strong>Lumbar Puncture:</strong> Elevated protein, normal cells (<5/mm¬≥). <span class="badge badge-blue">Albuminocytological dissociation</span>. <em>May be normal in first 2 weeks.</em></li>
                    <li><strong>Nerve Conduction Studies:</strong> Abnormal in most pts early. Look for demyelination (prolonged latencies, slowed conduction).</li>
                    <li><strong>Spirometry:</strong> VC, MIP, MEP every 6h.</li>
                    <li><strong>Anti-ganglioside Ab:</strong> If clinical atypical (e.g., GQ1b for Miller-Fisher).</li>
                </ul>
            </div>
        </div>

        <!-- Precipitating Factors -->
        <div class="card info">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M19.35 10.04C18.67 6.59 15.64 4 12 4 9.11 4 6.6 5.64 5.35 8.04 2.34 8.36 0 10.91 0 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95C8.08 7.14 9.94 6 12 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11c1.56.1 2.78 1.41 2.78 2.96 0 1.65-1.35 3-3 3z"/></svg>
                Common Triggers (Hx)
            </h3>
            <div class="stat-grid">
                <div class="stat-item">
                    <span class="stat-val">2/3</span>
                    <span class="stat-label">Have antecedent infection (6 wks prior)</span>
                </div>
                <div class="stat-item">
                    <span class="stat-val">30%</span>
                    <span class="stat-label"><em>C. jejuni</em> (Gastroenteritis)</span>
                </div>
                <div class="stat-item">
                    <span class="stat-val">CMV</span>
                    <span class="stat-label">EBV, Mycoplasma, Zika, COVID-19</span>
                </div>
                <div class="stat-item">
                    <span class="stat-val">Rare</span>
                    <span class="stat-label">Post-vaccination</span>
                </div>
            </div>
        </div>
        
        <!-- Subtypes -->
        <div class="card info">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M4 6H2v14c0 1.1.9 2 2 2h14v-2H4V6zm16-4H8c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V4c0-1.1-.9-2-2-2zm-1 9H9V9h10v2zm-4 4H9v-2h6v2zm4-8H9V5h10v2z"/></svg>
                Classification & Variants
            </h3>
            <div class="card-content">
                <ul>
                    <li><strong>AIDP:</strong> Most common (Western). Demyelinating.</li>
                    <li><strong>AMAN:</strong> Axonal motor. Common in Asia/Summer. <em>C. jejuni</em> link. Rapid progression.</li>
                    <li><strong>AMSAN:</strong> Axonal sensory & motor. Severe, poor recovery.</li>
                    <li><strong>Miller-Fisher (MFS):</strong> Ophthalmoplegia, Ataxia, Areflexia. Anti-GQ1b+. Benign.</li>
                </ul>
            </div>
        </div>

    </section>

    <!-- SECTION 3: MANAGEMENT -->
    <section id="management" class="tab-content grid-2">
        
        <!-- Specific Treatment -->
        <div class="card success">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zm-9 14l-5-5 1.41-1.41L10 14.17l7.59-7.59L19 8l-9 9z"/></svg>
                Disease Modifying Therapy
            </h3>
            <div class="card-content">
                <p style="margin-bottom: 10px;">Start as soon as possible after diagnosis (within 2 weeks ideally).</p>
                <div class="highlight-box" style="background: #e8f5e9; border-color: #66bb6a;">
                    <strong>Option 1:</strong> <br>IV Immunoglobulin (IVIG)<br>
                    <em>Dose:</em> 2 g/kg divided over 5 days.
                </div>
                <div class="highlight-box" style="background: #e8f5e9; border-color: #66bb6a;">
                    <strong>Option 2:</strong> <br>Plasma Exchange (PLEX)<br>
                    <em>Regimen:</em> 5 exchanges over 1-2 weeks.
                </div>
                <p style="font-size: 0.85rem; margin-top: 10px;"><em>Combination therapy is generally not better than either alone.</em></p>
            </div>
        </div>

        <!-- Supportive Care -->
        <div class="card success">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M12 21.35l-1.45-1.32C5.4 15.36 2 12.28 2 8.5 2 5.42 4.42 3 7.5 3c1.74 0 3.41.81 4.5 2.09C13.09 3.81 14.76 3 16.5 3 19.58 3 22 5.42 22 8.5c0 3.78-3.4 6.86-8.55 11.54L12 21.35z"/></svg>
                Supportive Care
            </h3>
            <div class="card-content">
                <ul>
                    <li><strong>Respiratory:</strong> Monitor VC. Intubate if VC <20 mL/kg or bulbar weakness with high aspiration risk.</li>
                    <li><strong>DVT Prophylaxis:</strong> Heparin/LMWH essential due to paralysis.</li>
                    <li><strong>Pain Control:</strong> Neuropathic pain (gabapentin, carbamazepine) or opioids for severe back pain.</li>
                    <li><strong>Rehab:</strong> Early physiotherapy to prevent contractures.</li>
                </ul>
            </div>
        </div>

        <!-- Prognosis -->
        <div class="card info" style="grid-column: span 2;">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M9 11H7v2h2v-2zm4 0h-2v2h2v-2zm4 0h-2v2h2v-2zm2-7h-1V2h-2v2H8V2H6v2H5c-1.11 0-1.99.9-1.99 2L3 20c0 1.1.89 2 2 2h14c1.1 0 2-.9 2-2V6c0-1.1-.9-2-2-2zm0 16H5V9h14v11z"/></svg>
                Prognosis & Recovery
            </h3>
            <div class="card-content" style="display: grid; grid-template-columns: repeat(auto-fit, minmax(200px, 1fr)); gap: 15px;">
                <div>
                    <strong>Recovery:</strong>
                    <p>Starts after plateau phase (days to weeks). Most recover completely.</p>
                </div>
                <div>
                    <strong>Poor Prognosis Indicators:</strong>
                    <ul style="margin-top: 5px;">
                        <li>Age > 60</li>
                        <li>Preceding <em>C. jejuni</em> diarrhea</li>
                        <li>AMAN/AMSAN subtypes</li>
                        <li>Low distal CMAP amplitude</li>
                    </ul>
                </div>
                <div>
                    <strong>Mortality:</strong>
                    <p>Approx 3-7%. Usually due to complications (pulmonary embolism, sepsis, cardiac arrest).</p>
                </div>
            </div>
        </div>
    </section>

    <!-- SECTION 4: DIFFERENTIALS -->
    <section id="differentials" class="tab-content grid-2">
        
        <div class="card info" style="grid-column: span 2;">
            <h3>
                <svg class="icon" viewBox="0 0 24 24"><path d="M10 20v-6h4v6h5v-8h3L12 3 2 12h3v8z"/></svg>
                Key Differentials
            </h3>
            <table class="comparison-table">
                <thead>
                    <tr>
                        <th>Condition</th>
                        <th>Key Differentiators from GBS</th>
                        <th>Key Test</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Transverse Myelitis</strong></td>
                        <td>Spinal level, early bowel/bladder dysfunction, UMN signs (hyperreflexia, Babinski).</td>
                        <td>MRI Spine</td>
                    </tr>
                    <tr>
                        <td><strong>Myasthenia Gravis</strong></td>
                        <p style="margin:0; font-size: 0.9rem">Fatigability, ocular involvement early, preserved reflexes, no sensory loss.</p>
                    </td>
                        <td>Repetitive Nerve Stimulation, Acetylcholine Receptor Ab</td>
                    </tr>
                    <tr>
                        <td><strong>Botulism</strong></td>
                        <td>Descending paralysis, fixed dilated pupils, dry mouth, constipation. Absent reflexes preserved early.</td>
                        <td>Stool culture/Toxin assay</td>
                    </tr>
                    <tr>
                        <td><strong>Lambert-Eaton (LEMS)</strong></td>
                        <td>Proximal weakness, dry mouth, reflexes potentiate with exercise. Often paraneoplastic (SCLC).</td>
                        <td>Voltage-gated Ca+ Channel Ab, EMG</td>
                    </tr>
                    <tr>
                        <td><strong>Poliomyelitis</strong></td>
                        <td>Fever, asymmetric pure motor weakness, intense myalgias.</td>
                        <td>Viral PCR/Stool Culture</td>
                    </tr>
                    <tr>
                        <td><strong>Acute Spinal Cord Compression</strong></td>
                        <td>Sensory level, back pain with tenderness, spasticity.</td>
                        <td>MRI Spine</td>
                    </tr>
                </tbody>
            </table>
        </div>

    </section>

    <footer style="text-align: center; margin-top: 30px; font-size: 0.8rem; color: var(--text-light);">
        <p>Source: BMJ Best Practice - Guillain-Barr√© Syndrome (Last updated Nov 10, 2022)</p>
        <p>For educational purposes only. Consult full guidelines for clinical decision making.</p>
    </footer>

    <script>
        function switchTab(tabId) {
            // Hide all contents
            document.querySelectorAll('.tab-content').forEach(content => {
                content.classList.remove('active');
            });
            // Deactivate all buttons
            document.querySelectorAll('.tab-btn').forEach(btn => {
                btn.classList.remove('active');
            });

            // Show selected content
            document.getElementById(tabId).classList.add('active');
            // Activate selected button
            // Find the button that called this function - simpler approach is looping
            const buttons = document.querySelectorAll('.tab-btn');
            buttons.forEach(btn => {
                if(btn.getAttribute('onclick').includes(tabId)) {
                    btn.classList.add('active');
                }
            });
        }
    </script>
</body>
</html>